Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

26.99USD
4:00pm EDT
Change (% chg)

$-0.51 (-1.85%)
Prev Close
$27.50
Open
$27.49
Day's High
$27.77
Day's Low
$26.94
Volume
75,912
Avg. Vol
120,353
52-wk High
$39.14
52-wk Low
$20.23

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, production and commercialization of products used in the process of manufacturing biologic drugs (bioprocessing). The Company is a manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $925.06
Shares Outstanding(Mil.): 33.64
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 115.03 36.15 37.05
EPS (TTM): 0.24 -- --
ROI: 6.51 15.11 14.35
ROE: 6.68 16.17 15.56

BRIEF-Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021

* Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 19 2016

BRIEF-Repligen Corp files for mixed shelf offering - SEC filing

* Repligen Corp files for mixed shelf offering, size not disclosed Source - http://bit.ly/1WExHpA Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

May 18 2016

BRIEF-Repligen to offer $100 mln of convertible senior notes

* Repligen announces proposed public offering of $100 million of convertible senior notes due 2021 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 18 2016

BRIEF-Repligen Q1 EPS $0.05

* Q1 earnings per share view $0.10 -- Thomson Reuters I/B/E/S

May 05 2016

BRIEF-Repligen acquires Atoll Gmbh

* Expects acquisition to be EPS accretive, on a GAAP basis, in 2017

Apr 04 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $124.89 -0.14
Novartis AG (NOVN.S) CHF82.20 -0.15
Roche Holding Ltd. (ROG.S) CHF248.80 -1.00
Roche Holding Ltd. (RO.S) CHF250.00 -2.25
Merck & Co., Inc. (MRK.N) $58.56 -0.26
Sanofi SA (SASY.PA) €76.51 -0.09
Amgen, Inc. (AMGN.OQ) $166.56 +0.89
Gilead Sciences, Inc. (GILD.OQ) $88.55 +2.00
Incyte Corporation (INCY.OQ) $86.43 +0.02

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.